Quan Capital

Quan Capital is a Shanghai-based venture capital firm specializing in early and growth-stage life sciences companies. Their unique investment philosophy enables them to explore disruptive solutions to critical healthcare problems impacting the lives of millions. Their portfolio companies are pioneers in breakthrough therapies and cutting-edge technologies that generate significant value to patients. In addition, they invest in leading players that fulfill the rapidly growing needs in a nascent innovation-driven ecosystem in China.

Empowered by strong expertise in both science and business, their investment professionals identify and nurture the next generation of great companies. They are deeply involved in company building and hands-on to support strategy, operation, and development. They contribute broad networks to bridge and smooth companies’ transformation between different development stages, maximizing company value across the value chain and varying geographies.

Their investment strategy focuses on identifying, incubating, and investing in innovative early and growth-stage companies globally and in China, with a focus on therapeutic biotech/pharma, enabling technologies/high-end specialty services, and companion diagnostics & precision medicine. They provide “smart capital” that brings broad scientific knowledge, cross-functional operational experiences, deep company-building leadership guidance, extensive global & local networks, and a unique combination of global vision/quality and China strength.